Document Classification

Section Type: RESULTS

Text: At the end of the study period, the L-carnitine-treated patients showed significant improvements compared with the placebo group in the following markers : oxidized LDL levels decreased by 15. 1 compared with 3. 0 U/L (P < 0. 001) ; LDL cholesterol decreased by 0. 45 compared with 0. 16 mmol/L (P < 0. 05) ; triglycerides decreased by 1. 02 compared with 0. 09 mmol/L (P < 0. 001) ; apolipoprotein A1 concentrations decreased by 0. 12 compared with 0. 03 mg/dL (P < 0. 05) ; apolipoprotein B-100 concentrations decreased by 0. 13 compared with 0. 04 mg/dL (P < 0. 05) ; thiobarbituric acid-reactive substance concentrations decreased by 1. 92 compared with 0. 05 (P < 0. 001), and conjugated diene concentrations decreased by 0. 72 compared with 0. 11 in the placebo group (P < 0. 001).